An interventional study of Elective cystectomy and Elective oophorectomy in Gynecologic Disease, Adnexal Mass and Adnexal Cyst, sponsored by Jean Dubuisson. Recruiting at 1 site in Switzerland. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-03-27.
Sponsored by Jean Dubuisson · Not applicable, Interventional, and Treatment
Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is a recent innovation in minimally invasive surgery which has already proven its non-inferiority to conventional abdominal laparoscopy (CAL) for hysterectomy in terms of efficiency and safety. However, the investigators note a lack of medical literature and no specific randomized controlled trial (RCT) assessing women's sexual function after vNOTES for benign adnexal surgery.
The aim of this RCT is to confirm the non-inferiority of the vNOTES approach for benign adnexal pathology compared to CAL on women's sexual function. Secondary outcomes will evaluate vNOTES's efficiency, morbidity and postoperative complications compared to CAL for benign adnexal surgery. The relationship between adnexal mass morcellation/aspiration and the quality of the histological analysis on surgical specimens will also be evaluated as secondary outcome.
This study focuses on women aged 18 to 70 who require surgery for benign adnexal disease (removal of an ovarian cyst, ovary and/or fallopian tube). This is a randomised study, i.e. each woman will be randomly assigned the surgical technique used for the planned operation, either vNOTES or conventional transabdominal laparoscopy.
Currently, there are no randomised clinical trials specifically investigating the impact on women's sexual quality of life after benign adnexal surgery compared to conventional transabdominal laparoscopy. Patients appear to be more reticent about the vaginal approach to surgery due to fear of possible alteration of their sexual activity afterwards. Indeed, their fears relate to the vaginal scarring that occurs during the vNOTES surgery. The vaginal scar could cause vaginal pain and pain during sexual intercourse, especially if there is a post-operative complication with the vaginal scar. The vaginal scar could also alter women's perception of their bodies during sexual intercourse. This study is necessary to answer these questions and increase women's acceptance of the vNOTES technique for benign adnexal surgery. In this way, women would benefit from the advantages of vNOTES without fearing an impact on their sexual quality of life.
The primary objective of this study is to demonstrate that the vNOTES technique, although using the vagina as an entry route, does not significantly alter the quality of sexual life of women after benign adnexal surgery compared to conventional transabdominal laparoscopy.
The secondary objectives of this study evaluate the effectiveness of vNOTES (impact on pain, length of stay after surgery and patient satisfaction), complications ( during surgery and up to 30 days after surgery), as well as the relationship between the need to cut the surgical specimen for extraction and the difficulty of microscopic analysis.
All participants in the study, regardless of the surgical technique assigned to them, will complete questionnaires to assess their quality of sexual life before surgery and at 3 and 6 months after surgery. These are the FSFI (female sexual function), CSI-16 (couple satisfaction) and a self-created questionnaire on pain during sex (dyspareunia). These questionnaires will determine whether there is a difference in the women's quality of sexual life before and after surgery, as well as comparing the two surgical techniques. The participants' general and medical data will be collected at the time of study enrolment, during hospitalisation and at one month after surgery to assess the secondary objectives of the study.
158 studies on the registry are indexed under Dyspareunia; 40 are open to participants now.
This study's planned enrollment of 62 is close to the median of 63 across 126 interventional studies indexed under Dyspareunia.
Browse Dyspareunia studies →This is the only study on the registry with Jean Dubuisson as lead sponsor.
Compared within Dyspareunia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Genital Diseases, Female. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Use of conventional transabdominal laparoscopy as the surgical approach to perform the indicated procedure in the included patient with benign adnexal pathology (elective cystectomy/oophorectomy elective salpingectomy or tubal sterilization).
Procedure: Elective cystectomy · Procedure: Elective oophorectomy · Procedure: Elective salpingectomy · Procedure: Elective tubal sterilization
Use of vNOTES (Transvaginal Natural Orifice Transluminal Endoscopic Surgery) as the surgical approach to perform the indicated procedure in the included patient with benign adnexal pathology (elective cystectomy/oophorectomy elective salpingectomy or tubal sterilization).
Procedure: Elective cystectomy · Procedure: Elective oophorectomy · Procedure: Elective salpingectomy · Procedure: Elective tubal sterilization
Adnexal cyst removal for presumed benign adnexal pathology.
Ovarian removal for presumed benign adnexal pathology.
Tubal removal for presumed benign adnexal pathology.
Tubal obstruction as a definitive contraceptive method (tubal cauterization with or without sectioning, partial or total removal of both tubes, or obstruction with small clips/ligatures).
Women's quality of sexual life evaluation - Female Sexual Function Index (FSFI)
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using the Female Sexual Function Index (FSFI) questionnaire. FSFI, created in 2000 by Raymond Rosen, is a reliable and complete multidimensional self-reported instrument for the measurement of female sexual function. It is validated in English and assesses 19 items divided into six domains of sexual function: (a) desire (2 items), (b) subjective arousal (4 items), (c) lubrication (4 items), (d) orgasm (3 items), (e) satisfaction (3 items) and (f) pain/discomfort (3 items). Each item focuses on the situation during the last 4 weeks. The total score is the sum of answers provided for each of the 6 domains. Lower is the score, worse is the patient's sexual function. A total score below 26 defines impaired sexual function.
Time frame: Preoperative
Women's quality of sexual life evaluation - Female Sexual Function Index (FSFI)
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using the Female Sexual Function Index (FSFI) questionnaire. FSFI, created in 2000 by Raymond Rosen, is a reliable and complete multidimensional self-reported instrument for the measurement of female sexual function. It is validated in English and assesses 19 items divided into six domains of sexual function: (a) desire (2 items), (b) subjective arousal (4 items), (c) lubrication (4 items), (d) orgasm (3 items), (e) satisfaction (3 items) and (f) pain/discomfort (3 items). Each item focuses on the situation during the last 4 weeks. The total score is the sum of answers provided for each of the 6 domains. Lower is the score, worse is the patient's sexual function. A total score below 26 defines impaired sexual function.
Time frame: 3 months postoperative
Women's quality of sexual life evaluation - Female Sexual Function Index (FSFI)
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using the Female Sexual Function Index (FSFI) questionnaire. FSFI, created in 2000 by Raymond Rosen, is a reliable and complete multidimensional self-reported instrument for the measurement of female sexual function. It is validated in English and assesses 19 items divided into six domains of sexual function: (a) desire (2 items), (b) subjective arousal (4 items), (c) lubrication (4 items), (d) orgasm (3 items), (e) satisfaction (3 items) and (f) pain/discomfort (3 items). Each item focuses on the situation during the last 4 weeks. The total score is the sum of answers provided for each of the 6 domains. Lower is the score, worse is the patient's sexual function. A total score below 26 defines impaired sexual function.
Time frame: 6 months postoperative
Women's quality of sexual life evaluation - Couple Satisfaction Index-16 (CSI-16)
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using the Couple Satisfaction Index-16 (CSI-16) questionnaire. CSI-16 is a precise, consistent and validated scale that evaluates the quality of a couple's relationship satisfaction. Each item is scored from 0 to 5 with different answer formats. The total score can range from 0 to 81. Higher is the total score, better is the relationship satisfaction. A relationship dissatisfaction is suggested when the total score is bellow 51,5.
Time frame: Preoperative
Women's quality of sexual life evaluation - Couple Satisfaction Index-16 (CSI-16)
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using the Couple Satisfaction Index-16 (CSI-16) questionnaire. CSI-16 is a precise, consistent and validated scale that evaluates the quality of a couple's relationship satisfaction. Each item is scored from 0 to 5 with different answer formats. The total score can range from 0 to 81. Higher is the total score, better is the relationship satisfaction. A relationship dissatisfaction is suggested when the total score is bellow 51,5.
Time frame: 3 months postoperative
Women's quality of sexual life evaluation - Couple Satisfaction Index-16 (CSI-16)
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using the Couple Satisfaction Index-16 (CSI-16) questionnaire. CSI-16 is a precise, consistent and validated scale that evaluates the quality of a couple's relationship satisfaction. Each item is scored from 0 to 5 with different answer formats. The total score can range from 0 to 81. Higher is the total score, better is the relationship satisfaction. A relationship dissatisfaction is suggested when the total score is bellow 51,5.
Time frame: 6 months postoperative
Women's quality of sexual life evaluation - Self reported questionnaire on dyspareunia
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using a self-reported questionnaire on dyspareunia. This questionnaire assesses presence of superficial and/or deep dyspareunia together with pain intensity. Pain intensity is assessed with the Visual Analog Scale (VAS) which rates the pain from 0 for no pain to 10 being the worst pain imaginable.
Time frame: Preoperative
Women's quality of sexual life evaluation - Self reported questionnaire on dyspareunia
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using a self-reported questionnaire on dyspareunia. This questionnaire assesses presence of superficial and/or deep dyspareunia together with pain intensity. Pain intensity is assessed with the Visual Analog Scale (VAS) which rates the pain from 0 for no pain to 10 being the worst pain imaginable.
Time frame: 3 months postoperative
Women's quality of sexual life evaluation - Self reported questionnaire on dyspareunia
Women's sexual Quality of Life evaluation after benigne adnexal surgery by vNOTES compared to Conventional Abdominal Laparoscopy using a self-reported questionnaire on dyspareunia. This questionnaire assesses presence of superficial and/or deep dyspareunia together with pain intensity. Pain intensity is assessed with the Visual Analog Scale (VAS) which rates the pain from 0 for no pain to 10 being the worst pain imaginable.
Time frame: 6 months postoperative
Effectiveness
Evaluation of the success rate (removal of the specimen without the need of conversion to laparoscopy or open-surgery) and the procedure duration including the need for adhesiolysis.
Time frame: Peroperative
Pain evaluation
Mean pain intensity will be evaluated with the Visual Analog Scale (VAS) which rates the pain intensity from 0 for no pain to 10 being the worst pain imaginable. Pain location will be assessed in a descriptive form.
Time frame: Preoperative
Lenght of stay
Evaluation of lenght of stay in days ranging from 0 for the day of the intervention to 30 for the 30th day after the intervention.
Time frame: During hospital stay, from day of the surgery up to 30 days after surgery
Pain evaluation
Pain intensity will be evaluated every day with the Visual Analog Scale (VAS) which rates the pain intensity from 0 for no pain to 10 being the worst pain imaginable. Names and classes of painkillers taken will be recorded daily during hospitalisation, noting the total milligram dosage per 24 hours for each drug (class 1 for simple analgesics, class 2 for addition of morphine derivatives, class 3 for morphine and morphine derivatives).
Time frame: During hospital stay, from day of the surgery up to 30 days after surgery
Pain evaluation
Mean pain intensity will be evaluated with the Visual Analog Scale (VAS) which rates the pain intensity from 0 for no pain to 10 being the worst pain imaginable. Pain location will be assessed in a descriptive form. Assessment of analgesic intake and class of painkillers when used (class 1 for simple analgesics, class 2 for addition of morphine derivatives, class 3 for morphine and morphine derivatives).
Time frame: 1 month postoperative
Complications rate
Failure to enter the peritoneal cavity, need for conversion, intraoperative complication during peritoneal cavity access, intraoperative blood loss, bowel or vessel injury.
Time frame: Peroperative
Complications rate
Delayed vaginal or parietal healing (abscess, hematoma, dehiscence), trocar-site hernia, trocar-site nerve injury, re-hospitalization and re-operation.
Time frame: 1 month postoperative
Histological analysis after morcellation/aspiration of the surgical specimen
Histological analysis after morcellation/aspiration of the surgical specimen : completed/ limited and diagnosis.
Time frame: Peroperative
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.